首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle
【24h】

The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle

机译:转录共激活因子PGC-1α介导运动诱导的骨骼肌血管生成

获取原文
获取原文并翻译 | 示例
       

摘要

Peripheral arterial disease (PAD) affects 5 million people in the US and is the primary cause of limb amputations. Exercise remains the single best intervention for PAD, in part thought to be mediated by increases in capillary density. How exercise triggers angiogenesis is not known. PPARγ coactivator (PGC)-1α is a potent transcriptional coactivator that regulates oxidative metabolism in a variety of tissues. We show here that PGC-1α mediates exercise-induced angiogenesis. Voluntary exercise induced robust angiogenesis in mouse skeletal muscle. Mice lacking PGC-1α in skeletal muscle failed to increase capillary density in response to exercise. Exercise strongly induced expression of PGC-1α from an alternate promoter. The induction of PGC-1α depended on β-adrenergic signaling. β-adrenergic stimulation also induced a broad program of angiogenic factors, including vascular endothelial growth factor (VEGF). This induction required PGC-1α. The orphan nuclear receptor ERRa mediated the induction of VEGF by PGC-1α, and mice lacking ERRα also failed to increase vascular density after exercise. These data demonstrate that β-adrenergic stimulation of a PGC-1α/ERRα/VEGF axis mediates exercise-induced angiogenesis in skeletal muscle.
机译:外周动脉疾病(PAD)在美国影响了500万人,是肢体截肢的主要原因。运动仍然是PAD的唯一最佳干预措施,部分被认为是由毛细血管密度的增加介导的。运动如何触发血管生成尚不清楚。 PPARγ辅助激活剂(PGC)-1α是一种有效的转录辅助激活剂,可调节多种组织中的氧化代谢。我们在这里显示PGC-1α介导运动诱导的血管生成。自愿运动在小鼠骨骼肌中诱导了强大的血管生成。骨骼肌中缺乏PGC-1α的小鼠无法响应运动而增加毛细血管密度。运动强烈诱导了来自替代启动子的PGC-1α的表达。 PGC-1α的诱导依赖于β-肾上腺素信号传导。 β-肾上腺素刺激还诱导了广泛的血管生成因子程序,包括血管内皮生长因子(VEGF)。该诱导需要PGC-1α。孤儿核受体ERRa通过PGC-1α介导VEGF的诱导,缺乏ERRα的小鼠也不能在运动后增加血管密度。这些数据证明,PGC-1α/ERRα/ VEGF轴的β-肾上腺素能刺激介导运动引起的骨骼肌血管生成。

著录项

  • 来源
  • 作者单位

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

    Dana Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, 44 Binney Street, Boston, MA 02115;

    Dana Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, 44 Binney Street, Boston, MA 02115;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215 Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University, Tokyo 113-8510, Japan;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    VEGF; ERRα; β-adrenergic;

    机译:VEGF;ERRα;β-肾上腺素;
  • 入库时间 2022-08-18 00:42:09

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号